Vector Science and Therapeutics Enters Investor Relations Agreement With RedChip

Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...

August 27, 2026 | Thursday | News
Andelyn Biosciences Partners With Queen’s University on AAV9-GM2 Gene Therapy

Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Q...

August 25, 2026 | Tuesday | News
IDT Expands DNA Synthesis Capa bilities to Support High-Diversity Genomics Programs

  Announcing expansion of capabilities to provide customers with a broader range of DNA synthesis solutions, allowing IDT to complement and extend ...

August 25, 2026 | Tuesday | News
Ipsen Completes Acquisition of Kartos Therapeutics, Adding Phase III Myelofibrosis Drug Candidate

Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navt...

August 24, 2026 | Monday | News
Pfizer and Valneva Lyme Disease Vaccine Application Validated by EMA

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  announced that the European Medicines Agency (EMA) has validated the Mar...

August 18, 2026 | Tuesday | News
Veloxis Pharmaceuticals to Pay $46 Million to Resolve Envarsus XR Fraud Case

In a major healthcare fraud enforcement action, Veloxis Pharmaceuticals will pay over million and accept a stringent deferred prosecution agreement ...

August 17, 2026 | Monday | News
Philips and Exor Update Long-Term Agreement, Raising Potential Stake to 22%

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. announced that they have agreed to update their long-term relat...

August 12, 2026 | Wednesday | News
Innovent Biologics to Commercialize Daiichi Sankyo’s Vanflyta in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML Innovent Biologics, Inc. (01801.HK) and ...

August 11, 2026 | Tuesday | News
Innate Pharma Partners with Sobi to Advance Lacutamab in Cutaneous T-Cell Lymphoma

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") and Swedish Orphan Biovitrum AB (publ) (Sobi®) announced that they h...

August 11, 2026 | Tuesday | News
IQVIA and Medera Partner to Advance Cardiac Gene Therapy Development

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...

August 06, 2026 | Thursday | News
Pathos AI and AstraZeneca Partner to Advance AZD4241 for ER+/HER2- Breast Cancer

Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and t...

August 05, 2026 | Wednesday | News
Ember LifeSciences and Alfresa Form Strategic Alliance to Strengthen Pharmaceutical Cold Chain in Japan

Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical cold chain solutions, has entered into a capital and business al...

July 31, 2026 | Friday | News
Massive Bio Partnered with GELL to Advance AI-Driven Oncology Research Across Latin America and the U.S.

-Massive Bio, a global leader in artificial intelligence-driven solutions for oncology, clinical trial matching, and patient navigation, and the Latin Am...

July 29, 2026 | Wednesday | News
arcoris bio Partnered with Europa Biosite to Expand immunoMUSE® Kit Distribution

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, announced a distribution partnership with Europa Biosite, a leading di...

July 23, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close